Tiziana Life Sciences
Quarterly Financials
| Values in thousands | 2025-03-31 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|
Gross Profit | -61 | -63 | -41 |
EBITDA | -8,699 | -7,917 | -8,579 |
EBIT | -8,760 | -7,980 | -8,620 |
Net Income | -7,209 | -4,654 | -9,074 |
Free Cash Flow | -1,931 | 772 | -4,306 |
Cash | 3,724 | 1,130 | 1,183 |
Basic Shares | 54,557 | 51,549 | 51,330 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -51 | -141 | ||
EBITDA | -17,136 | -15,339 | -26,340 | |
EBIT | -15,794 | -17,232 | -15,390 | -26,481 |
Net Income | -11,863 | -17,691 | -15,397 | -23,417 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -1,545 | -15,698 | -19,615 | -21,784 |
Cash | 3,724 | 1,183 | 18,122 | 42,186 |
Basic Shares | 111,462 | 50,763 | 50,763 | 48,966 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-03-31 | -$0.07 |
2024-09-30 | -$0.05 |
2022-09-30 | -$0.06 |
2022-03-31 | -$0.06 |
